Anti-Human RSPO3 Therapeutical Antibody

Recombinant monoclonal antibody expressed in CHO binding to Human RSPO3. Anti-RSPO3 is the first drug in its class to target the R-spondin-LGR pathway, and has shown robust preclinical activity against a number of solid tumor types.
Supplier Creative Biolabs
Product # TAB-755CL
Pricing Inquiry
Type Antibody
Storage Store at -20°C. Avoid multiple freeze/thaw cycles.
Target RSPO3
Species Reactivity Human
Feedback